22 research outputs found
Analisis Penerapan Sistem Akuntansi Penjualan Kredit Dan Penerimaan Kas Dalam Mendukung Pengendalian Intern Perusahaan (Studi Kasus PT. Smart Tbk Refinery Surabaya)
System of selling credit accounting and system of cash receiving from account receivable is the source of life to achieving company goals. This research on the system of credit sales and cash receipts to support the company internal control. This research was conducted at PT. SMART Tbk Refinery Surabaya. PT. SMART Tbk Refinery Surabaya only selling cooking oil in the form of branded product and trading product on credit. PT. SMART Tbk Refinery Surabaya still has any weakness on system of selling credit accounting and system of cash receiving from account receivable, some of the sales transaction activity that occurred less supportive of the company\u27s internal control. This study aims to provide information to companies about the advantages and weakness of credit sales accounting system and cash receipts that have been applied by the company
High Field Solid-State NMR Spectroscopy Investigation of <sup>15</sup>N‑Labeled Rosette Nanotubes: Hydrogen Bond Network and Channel-Bound Water
<sup>15</sup>N-labeled rosette nanotubes were synthesized and investigated
using high-field solid-state NMR spectroscopy, X-ray diffraction,
atomic force microscopy, and electron microscopy. The results established
the H-bond network involved in the self-assembly of the nanostructure
as well as bound water molecules in the nanotube’s channel
Heat map of metabolomic differences between HFrEF and controls.
<p>Heat maps were generated with the concentrations of potential candidate metabolites with univariate analysis. Similar metabolites were arranged together for use in pathway analysis through intuitive pattern discovery. The heat map displays an increase in each metabolite in relative concentration as a red color and a decrease in a metabolite as a blue color. The metabolites are listed at the left side of each row, and the subjects are shown at the bottom of each column.</p
Heat map of metabolomic differences between HFpEF and controls.
<p>Heat maps were generated with the concentrations of potential candidate metabolites with univariate analysis. Similar metabolites were arranged together for use in pathway analysis through intuitive pattern discovery. The heat map displays an increase in each metabolite in relative concentration as a red color and a decrease in a metabolite as a blue color. The metabolites are listed at the left side of each row, and the subjects are shown at the bottom of each column.</p
Unadjusted Comparisons.
<p>The NRI and IDI values are of the blended “natriuretic peptide & metabolites” model versus each individual model.</p><p>AUC = Area Under the Curve, NRI = Net Reclassification Improvement, IDI = Integrated Discrimination Improvement, CI = Confidence Interval</p><p>Unadjusted Comparisons.</p
Heat map of metabolomic differences between HFpEF and HFrEF.
<p>Heat maps were generated with the concentrations of potential candidate metabolites with univariate analysis. Similar metabolites were arranged together for use in pathway analysis through intuitive pattern discovery. The heat map displays an increase in each metabolite in relative concentration as a red color and a decrease in a metabolite as a blue color. The metabolites are listed at the left side of each row, and the subjects are shown at the bottom of each column.</p
Cardiac peptides and left ventricular ejection fraction (LVEF) in control and HF patients.
<p>Ambulatory patients with clinical diagnosis of HFpEF (n = 24), HFrEF (n = 20), and age-matched controls (n = 38) were selected for metabolomics analysis as part of the Alberta HEART (<u>H</u>eart Failure <u>E</u>tiology and <u>A</u>nalysis <u>R</u>esearch <u>T</u>eam) project. Plasma BNP and NT-proBNP levels were measured using a Biosite Triage reagent pack and Elecsys 2010 proBNP assay, respectively. LVEF was assessed by echocardiography and interpreted by cardiologists blinded to the metabolomics analysis. Data are presented as the median ± IQR. * p < 0.05 compared to the control group, # p < 0.05 compared to the HFpEF group.</p
Demographic Details of Participants.
<p>* p-value < 0.05 compared to control</p><p><sup>†</sup> p-value < 0.05 compared to HFpEF</p><p>HFpEF = Heart Failure with Preserved Ejection Fraction, HFrEF = Heart Failure with reduced Ejection Fraction, NYHA = New York Heart Association, CAD = Coronary Artery Disease, LVEF = Left Ventricular Ejection Fraction, BMI = Body Mass Index, BNP = B-type Natriuretic Peptide, NT-proBNP = N terminal pro-BNP, ACEI = Angiotensin Converting Enzyme Inhibitor, ARB = Angiotensin Receptor Blocker, CCB = Calcium Channel Blocker.</p><p>Demographic Details of Participants.</p
Historic data on metabolite characterization of human urine by different platforms.
<p>Historic data on metabolite characterization of human urine by different platforms.</p
Concentrations of isoflavones and thiols as determined by HPLC.
a<p>Isoflavone metabolites measured by HPLC/UV.</p>b<p>Thiol metabolites measured by HPLC/FD.</p><p>Oc: occurrence;</p><p>NA: not available.</p